U.S. flag

An official website of the United States government

Display Settings:

Format

Send to:

Choose Destination
Accession: PRJNA541941 ID: 541941

Effect of Idelalisib in follicular lymphoma monocultures and cocultured with follicular dendritic cells (FDC) (human)

See Genome Information for Homo sapiens
Follicular Lymphoma primary cells (FL) were treated with the PI3K delta inhibitor idelalisib (500nM, 48h) in the presence or absence of follicular dendritic cells We used microarrays to uncover the mechanisms underlying mechanism of resistance and sensitivity of FL to idelalisib Overall design: Global RNA expression was done in five primary FL biopsies treated in vitro with idelalisib in monoculture or cocultured with follicular dendritic cells
AccessionPRJNA541941; GEO: GSE130918
Data TypeTranscriptome or Gene expression
ScopeMultiisolate
OrganismHomo sapiens[Taxonomy ID: 9606]
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo; Homo sapiens
PublicationsSerrat N et al., "PI3Kδ inhibition reshapes follicular lymphoma-immune microenvironment cross talk and unleashes the activity of venetoclax.", Blood Adv, 2020 Sep 8;4(17):4217-4231
SubmissionRegistration date: 8-May-2019
Hemato-oncology, IDIBAPS
RelevanceMedical
Project Data:
Resource NameNumber
of Links
Publications
PubMed1
PMC1
Other datasets
GEO DataSets1
GEO Data Details
ParameterValue
Data volume, Spots616460
Data volume, Processed Mbytes14
Data volume, Supplementary Mbytes40

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center